Our top pick for
This article contains links to products or services from one or more of our advertisers or partners. We may receive a commission when you click or make a purchase using our site. Learn more about how we make money.
Microbot Medical Inc is a medical instruments & supplies business based in the US. Microbot Medical shares (MBOT) are listed on the NASDAQ and all prices are listed in US Dollars. Microbot Medical employs 10 staff and has a market cap (total outstanding shares value) of USD$53.3 million.
|Latest market close||USD$7.46|
|52-week range||USD$4.3 - USD$15.75|
|50-day moving average||USD$7.5106|
|200-day moving average||USD$7.2272|
|Wall St. target price||USD$20|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-1.71|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-11-25)||2.61%|
|1 month (2020-11-06)||2.75%|
|3 months (2020-09-04)||17.11%|
|6 months (2020-06-04)||1.63%|
|1 year (2019-12-04)||50.71%|
|2 years (2018-12-04)||309.89%|
|3 years (2017-12-04)||578.18%|
|5 years (2015-12-04)||1,334.62%|
|Gross profit TTM||USD$0|
|Return on assets TTM||-26.98%|
|Return on equity TTM||-51.11%|
|Market capitalisation||USD$53.3 million|
TTM: trailing 12 months
There are currently 371,619 Microbot Medical shares held short by investors – that's known as Microbot Medical's "short interest". This figure is 16.3% down from 443,856 last month.
There are a few different ways that this level of interest in shorting Microbot Medical shares can be evaluated.
Microbot Medical's "short interest ratio" (SIR) is the quantity of Microbot Medical shares currently shorted divided by the average quantity of Microbot Medical shares traded daily (recently around 127704.12371134). Microbot Medical's SIR currently stands at 2.91. In other words for every 100,000 Microbot Medical shares traded daily on the market, roughly 2910 shares are currently held short.
However Microbot Medical's short interest can also be evaluated against the total number of Microbot Medical shares, or, against the total number of tradable Microbot Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Microbot Medical's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Microbot Medical shares in existence, roughly 50 shares are currently held short) or 0.0557% of the tradable shares (for every 100,000 tradable Microbot Medical shares, roughly 56 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Microbot Medical.
Find out more about how you can short Microbot Medical stock.
We're not expecting Microbot Medical to pay a dividend over the next 12 months.
Microbot Medical's shares were split on a 1:15 basis on 5 September 2018. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Microbot Medical shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Microbot Medical shares which in turn could have impacted Microbot Medical's share price.
Over the last 12 months, Microbot Medical's shares have ranged in value from as little as $4.3 up to $15.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Microbot Medical's is 5.1407. This would suggest that Microbot Medical's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable self-propelled locomotive device to treat capabilities within tubular lumens, such as the blood vessels, respiratory, and the urinary and GI tracts; a combination of a guidewire and microcatheter technologies that are used for endoluminal surgery; and maneuver guidewire, microcatheters, and over-the-wire devices within the body's vasculature. It has 37 issued/allowed patents and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
Steps to owning and managing HTZ, with 24-hour and historical pricing before you buy.
Steps to owning and managing HELE, with 24-hour and historical pricing before you buy.
Steps to owning and managing HE, with 24-hour and historical pricing before you buy.
Steps to owning and managing GKOS, with 24-hour and historical pricing before you buy.
Steps to owning and managing EYEN, with 24-hour and historical pricing before you buy.
Steps to owning and managing EXAS, with 24-hour and historical pricing before you buy.
Steps to owning and managing EVFM, with 24-hour and historical pricing before you buy.
Steps to owning and managing MRAM, with 24-hour and historical pricing before you buy.
Steps to owning and managing EQNR, with 24-hour and historical pricing before you buy.
Steps to owning and managing SOLO, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.